184 related articles for article (PubMed ID: 15773736)
21. Managing pulmonary embolism from presentation to extended treatment.
Cohen AT; Dobromirski M; Gurwith MM
Thromb Res; 2014 Feb; 133(2):139-48. PubMed ID: 24182642
[TBL] [Abstract][Full Text] [Related]
22. Thrombolysis for pulmonary embolism and venous thrombosis: is it worthwhile?
Douma RA; Kamphuisen PW
Semin Thromb Hemost; 2007 Nov; 33(8):821-8. PubMed ID: 18175288
[TBL] [Abstract][Full Text] [Related]
23. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
24. Low-molecular-weight heparin compared with intravenous unfractionated heparin for treatment of pulmonary embolism: a meta-analysis of randomized, controlled trials.
Quinlan DJ; McQuillan A; Eikelboom JW
Ann Intern Med; 2004 Feb; 140(3):175-83. PubMed ID: 14757615
[TBL] [Abstract][Full Text] [Related]
25. Outpatient treatment of patients with pulmonary embolism.
Wells PS; Büller HR
Semin Vasc Med; 2001 Nov; 1(2):229-34. PubMed ID: 15199507
[TBL] [Abstract][Full Text] [Related]
26. Treatment of deep vein thrombosis in patients with pulmonary embolism: subgroup analysis on the efficacy and safety of certoparin vs. unfractionated heparin.
Riess H; Becker LK; Melzer N; Harenberg J
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):838-44. PubMed ID: 25004024
[TBL] [Abstract][Full Text] [Related]
27. Acute pulmonary embolism. Part 2: treatment.
van Es J; Douma RA; Gerdes VE; Kamphuisen PW; Büller HR
Nat Rev Cardiol; 2010 Nov; 7(11):613-22. PubMed ID: 20842179
[TBL] [Abstract][Full Text] [Related]
28. Prophylaxis against venous thromboembolism in orthopedic surgery.
Liu LT; Ma BT
Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000
[TBL] [Abstract][Full Text] [Related]
29. Duration of anticoagulation therapy for venous thromboembolism.
Bounameaux H; Perrier A
Hematology Am Soc Hematol Educ Program; 2008; ():252-8. PubMed ID: 19074092
[TBL] [Abstract][Full Text] [Related]
30. Current perspectives on the treatment of venous thromboembolism: need for effective, safe and convenient new antithrombotic drugs.
O'Shaughnessy DF
Int J Clin Pract; 2004 Mar; 58(3):277-84. PubMed ID: 15117096
[TBL] [Abstract][Full Text] [Related]
31. Tinzaparin sodium: a low-molecular-weight heparin.
Neely JL; Carlson SS; Lenhart SE
Am J Health Syst Pharm; 2002 Aug; 59(15):1426-36. PubMed ID: 12166042
[TBL] [Abstract][Full Text] [Related]
32. Treatment of venous thromboembolism.
Nazario R; Delorenzo LJ; Maguire AG
Cardiol Rev; 2002; 10(4):249-59. PubMed ID: 12144736
[TBL] [Abstract][Full Text] [Related]
33. Deep Venous Thrombosis and Pulmonary Embolism: Current Therapy.
Wilbur J; Shian B
Am Fam Physician; 2017 Mar; 95(5):295-302. PubMed ID: 28290648
[TBL] [Abstract][Full Text] [Related]
34. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis.
Roderick P; Ferris G; Wilson K; Halls H; Jackson D; Collins R; Baigent C
Health Technol Assess; 2005 Dec; 9(49):iii-iv, ix-x, 1-78. PubMed ID: 16336844
[TBL] [Abstract][Full Text] [Related]
35. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
van der Heijden JF; Hutten BA; Büller HR; Prins MH
Cochrane Database Syst Rev; 2002; (1):CD002001. PubMed ID: 11869618
[TBL] [Abstract][Full Text] [Related]
36. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
Ageno W; Mantovani LG; Haas S; Kreutz R; Monje D; Schneider J; van Eickels M; Gebel M; Zell E; Turpie AG
Lancet Haematol; 2016 Jan; 3(1):e12-21. PubMed ID: 26765643
[TBL] [Abstract][Full Text] [Related]
37. Current management of acute symptomatic deep vein thrombosis.
Heit JA
Am J Cardiovasc Drugs; 2001; 1(1):45-50. PubMed ID: 14728051
[TBL] [Abstract][Full Text] [Related]
38. Antithrombotic therapy for venous thromboembolic disease.
Hyers TM; Agnelli G; Hull RD; Morris TA; Samama M; Tapson V; Weg JG
Chest; 2001 Jan; 119(1 Suppl):176S-193S. PubMed ID: 11157648
[No Abstract] [Full Text] [Related]
39. Economic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patients.
Knight KK; Wong J; Hauch O; Wygant G; Aguilar D; Ofman JJ
Value Health; 2005; 8(3):191-200. PubMed ID: 15877591
[TBL] [Abstract][Full Text] [Related]
40. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?].
Ruiz Manzano J; Monreal M
Med Clin (Barc); 1998 Nov; 111(18):697-9. PubMed ID: 9887434
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
